No More Shots: Pill Versions of Ozempic-Like Drugs Are Coming

[ad_1] Tablets could appeal to people who want to lose weight but despise needles, which injections like Ozempic require. [ad_2] Source link

Alzheimer’s Blockbuster Is Coming, but Slowly

[ad_1] Developers of Alzheimer’s drugs have work cut out for them getting the treatments to patients. [ad_2] Source link

Obesity Could Be Pharma’s Biggest Blockbuster Yet

[ad_1] Medications like Wegovy and Mounjaro are about to create one of the biggest drug categories of all time, with massive implications for patients, investors and the healthcare system.The excitement…

Eli Lilly Results Signal Arrival of Blockbuster New Drug Class

[ad_1] Share Listen (2 min) [ad_2] Source link

Weight-Loss Drugmakers Lobby for Medicare Coverage

[ad_1] Adding Ozempic and Mounjaro to federal plans, whose prescription benefit excludes weight drugs, could stoke sales. [ad_2] Source link

Amazon, Facebook, Google Headline Busy Earnings Week for Tech

[ad_1] PepsiCo, McDonald’s and Exxon are also set to report amid concerns about the economy and inflation. [ad_2] Source link

Demand for Obesity Drugs Has Insurers Paying Close Attention

[ad_1] Markets Heard on the Street Strong sales of obesity-diabetes drugs known as GLP-1s could affect insurance companies’ financial results [ad_2] Source link

WeightWatchers Gets a Makeover With Obesity-Drug Business

[ad_1] Markets Heard on the Street The decision to get into the business for drugs such as Ozempic makes sense [ad_2] Source link

Eli Lilly Is Priced for Perfection in the Obesity Market

[ad_1] The company has outperformed its pharma peers in recent years, but its valuation leaves little room for error. [ad_2] Source link

Diabetes Drug Giant Sanofi Cuts Insulin Prices by Up to 78%

[ad_1] Health Sanofi says it would cap patients’ out-of-pocket costs for Lantus insulin at $35 a month [ad_2] Source link